TMS-EEG signatures of glutamatergic neurotransmission in human cortex

Abstract Neuronal activity in the brain reflects an excitation–inhibition balance that is regulated predominantly by glutamatergic and GABAergic neurotransmission, and often disturbed in neuropsychiatric disorders. Here, we tested the effects of a single oral dose of two anti-glutamatergic drugs (de...

Full description

Bibliographic Details
Main Authors: Paolo Belardinelli, Franca König, Chen Liang, Isabella Premoli, Debora Desideri, Florian Müller-Dahlhaus, Pedro Caldana Gordon, Carl Zipser, Christoph Zrenner, Ulf Ziemann
Format: Article
Language:English
Published: Nature Portfolio 2021-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-87533-z
_version_ 1818424821711634432
author Paolo Belardinelli
Franca König
Chen Liang
Isabella Premoli
Debora Desideri
Florian Müller-Dahlhaus
Pedro Caldana Gordon
Carl Zipser
Christoph Zrenner
Ulf Ziemann
author_facet Paolo Belardinelli
Franca König
Chen Liang
Isabella Premoli
Debora Desideri
Florian Müller-Dahlhaus
Pedro Caldana Gordon
Carl Zipser
Christoph Zrenner
Ulf Ziemann
author_sort Paolo Belardinelli
collection DOAJ
description Abstract Neuronal activity in the brain reflects an excitation–inhibition balance that is regulated predominantly by glutamatergic and GABAergic neurotransmission, and often disturbed in neuropsychiatric disorders. Here, we tested the effects of a single oral dose of two anti-glutamatergic drugs (dextromethorphan, an NMDA receptor antagonist; perampanel, an AMPA receptor antagonist) and an L-type voltage-gated calcium channel blocker (nimodipine) on transcranial magnetic stimulation (TMS)-evoked electroencephalographic (EEG) potentials (TEPs) and TMS-induced oscillations (TIOs) in 16 healthy adults in a pseudorandomized, double-blinded, placebo-controlled crossover design. Single-pulse TMS was delivered to the hand area of left primary motor cortex. Dextromethorphan increased the amplitude of the N45 TEP, while it had no effect on TIOs. Perampanel reduced the amplitude of the P60 TEP in the non-stimulated hemisphere, and increased TIOs in the beta-frequency band in the stimulated sensorimotor cortex, and in the alpha-frequency band in midline parietal channels. Nimodipine and placebo had no effect on TEPs and TIOs. The TEP results extend previous pharmaco-TMS-EEG studies by demonstrating that the N45 is regulated by a balance of GABAAergic inhibition and NMDA receptor-mediated glutamatergic excitation. In contrast, AMPA receptor-mediated glutamatergic neurotransmission contributes to propagated activity reflected in the P60 potential and midline parietal induced oscillations. This pharmacological characterization of TMS-EEG responses will be informative for interpreting TMS-EEG abnormalities in neuropsychiatric disorders with pathological excitation–inhibition balance.
first_indexed 2024-12-14T14:04:08Z
format Article
id doaj.art-7ef4d5033f584e31b11159a369683d7b
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T14:04:08Z
publishDate 2021-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-7ef4d5033f584e31b11159a369683d7b2022-12-21T22:58:37ZengNature PortfolioScientific Reports2045-23222021-04-0111111410.1038/s41598-021-87533-zTMS-EEG signatures of glutamatergic neurotransmission in human cortexPaolo Belardinelli0Franca König1Chen Liang2Isabella Premoli3Debora Desideri4Florian Müller-Dahlhaus5Pedro Caldana Gordon6Carl Zipser7Christoph Zrenner8Ulf Ziemann9Department of Neurology and Stroke, University of TübingenDepartment of Neurology and Stroke, University of TübingenDepartment of Neurology and Stroke, University of TübingenDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College LondonDepartment of Neurology and Stroke, University of TübingenDepartment of Neurology and Stroke, University of TübingenDepartment of Neurology and Stroke, University of TübingenDepartment of Neurology and Stroke, University of TübingenDepartment of Neurology and Stroke, University of TübingenDepartment of Neurology and Stroke, University of TübingenAbstract Neuronal activity in the brain reflects an excitation–inhibition balance that is regulated predominantly by glutamatergic and GABAergic neurotransmission, and often disturbed in neuropsychiatric disorders. Here, we tested the effects of a single oral dose of two anti-glutamatergic drugs (dextromethorphan, an NMDA receptor antagonist; perampanel, an AMPA receptor antagonist) and an L-type voltage-gated calcium channel blocker (nimodipine) on transcranial magnetic stimulation (TMS)-evoked electroencephalographic (EEG) potentials (TEPs) and TMS-induced oscillations (TIOs) in 16 healthy adults in a pseudorandomized, double-blinded, placebo-controlled crossover design. Single-pulse TMS was delivered to the hand area of left primary motor cortex. Dextromethorphan increased the amplitude of the N45 TEP, while it had no effect on TIOs. Perampanel reduced the amplitude of the P60 TEP in the non-stimulated hemisphere, and increased TIOs in the beta-frequency band in the stimulated sensorimotor cortex, and in the alpha-frequency band in midline parietal channels. Nimodipine and placebo had no effect on TEPs and TIOs. The TEP results extend previous pharmaco-TMS-EEG studies by demonstrating that the N45 is regulated by a balance of GABAAergic inhibition and NMDA receptor-mediated glutamatergic excitation. In contrast, AMPA receptor-mediated glutamatergic neurotransmission contributes to propagated activity reflected in the P60 potential and midline parietal induced oscillations. This pharmacological characterization of TMS-EEG responses will be informative for interpreting TMS-EEG abnormalities in neuropsychiatric disorders with pathological excitation–inhibition balance.https://doi.org/10.1038/s41598-021-87533-z
spellingShingle Paolo Belardinelli
Franca König
Chen Liang
Isabella Premoli
Debora Desideri
Florian Müller-Dahlhaus
Pedro Caldana Gordon
Carl Zipser
Christoph Zrenner
Ulf Ziemann
TMS-EEG signatures of glutamatergic neurotransmission in human cortex
Scientific Reports
title TMS-EEG signatures of glutamatergic neurotransmission in human cortex
title_full TMS-EEG signatures of glutamatergic neurotransmission in human cortex
title_fullStr TMS-EEG signatures of glutamatergic neurotransmission in human cortex
title_full_unstemmed TMS-EEG signatures of glutamatergic neurotransmission in human cortex
title_short TMS-EEG signatures of glutamatergic neurotransmission in human cortex
title_sort tms eeg signatures of glutamatergic neurotransmission in human cortex
url https://doi.org/10.1038/s41598-021-87533-z
work_keys_str_mv AT paolobelardinelli tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT francakonig tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT chenliang tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT isabellapremoli tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT deboradesideri tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT florianmullerdahlhaus tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT pedrocaldanagordon tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT carlzipser tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT christophzrenner tmseegsignaturesofglutamatergicneurotransmissioninhumancortex
AT ulfziemann tmseegsignaturesofglutamatergicneurotransmissioninhumancortex